2016
DOI: 10.1371/journal.pone.0145134
|View full text |Cite
|
Sign up to set email alerts
|

Choose Your Weaponry: Selective Storage of a Single Toxic Compound, Latrunculin A, by Closely Related Nudibranch Molluscs

Abstract: Natural products play an invaluable role as a starting point in the drug discovery process, and plants and animals use many interesting biologically active natural products as a chemical defense mechanism against predators. Among marine organisms, many nudibranch gastropods are known to derive defensive metabolites from the sponges they eat. Here we investigated the putative sequestration of the toxic compound latrunculin A—a 16-membered macrolide that prevents actin polymerization within cellular processes—wh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
70
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 50 publications
(71 citation statements)
references
References 55 publications
(72 reference statements)
1
70
0
Order By: Relevance
“…However, as is true for plants that simultaneously use visual and olfactory aposematic signals for animal attraction (45), T. striata uses double signaling, but for defensive purposes, whereas M. edwardsi relies on olfactory aposematism, which may provide protection from a wider range of predators, including those lacking efficient visual systems (35). It is worth underlining here that compounds 1-3 induce both toxic and olfactory-guided food avoidance effects and, differently from the cases considered by Eisner and Grant (44), they function as conditioned olfactory stimuli for indicating their own intrinsic toxicity and unprofitability.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, as is true for plants that simultaneously use visual and olfactory aposematic signals for animal attraction (45), T. striata uses double signaling, but for defensive purposes, whereas M. edwardsi relies on olfactory aposematism, which may provide protection from a wider range of predators, including those lacking efficient visual systems (35). It is worth underlining here that compounds 1-3 induce both toxic and olfactory-guided food avoidance effects and, differently from the cases considered by Eisner and Grant (44), they function as conditioned olfactory stimuli for indicating their own intrinsic toxicity and unprofitability.…”
Section: Discussionmentioning
confidence: 99%
“…The feeding deterrence activity of compounds 1-3 was evaluated against the cooccurring generalist shrimp Palaemon elegans Rathke, 1837, following an approach already used to assess the palatability of other bioactive metabolites (31), including marine furanosesquiterpenes (32,33). Like other palaemonid species (34,35), P. elegans is suitable for evaluations of this kind, which require a good view of the ingested food in the digestive system (31). Given that decapod crustaceans exhibit complex learning ability (36,37), the possibility that the shrimp learn to avoid the compounds after experiencing aversive olfactory stimuli was also considered.…”
mentioning
confidence: 99%
“…Some closely-related Chromodoris spp. have been shown to selectively accumulate a 16-membered macrolide, latrunculin A, in the mantle parts, leaving other secondary metabolites in the viscera [30]. A recent study has reported the exclusive incorporation of (−)-furodysinin in the dorsal horn of Ceratosoma trilobatum and Ceratosoma gracilimum , emphasizing the protective function of the dorsal horn in Ceratosoma nudibranchs [31].…”
Section: Resultsmentioning
confidence: 99%
“…However, they emphasize a lot of evidence showing that the actual producers of the bioactive substances are associated microorganisms (mainly heterotrophic bacteria and cyanobacteria). In addition, a trophic transfer of the compounds from sponges to their specialist nudibranch predators is also described …”
Section: Marine Natural Products As Sources Of New Anticancer Drugsmentioning
confidence: 99%